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A B S T R A C T
Objective: Reduced CD16 expression is associated with neutrophil apoptosis. This study aimed to
compare CD16 expression on neutrophils in the vagina from women with normal bacterial ﬂora and with
vaginitis.
Study design: Vaginal lavages were sampled from volunteers diagnosed with bacterial vaginosis (BV,
n = 34), vulvovaginal candidiasis (VC, n = 43), BV plus VC (BV + VC, n = 14), and normal ﬂora (NF, n = 51).
Neutrophils were identiﬁed by expression of CD15, CD16 and CD24 surface markers as assessed by ﬂow
cytometry.
Results: CD16 expression was elevated in neutrophils from women with vaginitis (BV p < 0.0001; VC
p = 0.01; BV + VC p = 0.0027) as compared to women with NF.
Conclusion: The reduction in CD16 down-regulation is consistent with prolonged neutrophil viability
and activity in the vagina of women with vaginitis. This may contribute to greater microbial clearance
and, conversely, with inﬂammation-associated pathology.
 2012 Elsevier Ireland Ltd. 
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Vulvovaginitides represent the most common problem in
gynecology clinics, causing considerable public health expendi-
tures plus emotional and social distress [1]. The most frequent
vaginitis affecting women of childbearing age is bacterial vaginosis
(BV) [2]. BV is a polymicrobial syndrome of unknown etiology
characterized by the replacement of lactobacillus-dominated
biotypes with bacteria such as Gardnerella vaginalis, Mobiluncus
sp., Mycoplasma hominis, Atopobium vaginae, Prevotella sp.,
Bacteroides sp. and Porphyromonas sp. [3,4]. Women with this
disordered vaginal ecosystem have increased susceptibility to
pelvic infections [5], postsurgical infections [6] and sexually
transmitted diseases including HIV [7]. BV has also been associated
with a higher risk of adverse pregnancy outcomes such as preterm
birth [8]. Vulvovaginal candidiasis (VC) is the second most
common vaginitis, with Candida albicans being responsible for
the vast majority (85–95%) of symptomatic cases. Candida glabrata,
Candida parapsilosis, Candida tropicalis, and Candida krusei are less
frequent causes of VC [9].* Corresponding author at: CAISM – UNICAMP, Rua Alexander Fleming 101,
Campinas, SP 13083-881, Brazil. Tel.: +55 19 35219462; fax: +55 19 35219433.
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Open access under the Elsevier OA license. The vaginal cavity in many women is colonized by Candida
and the bacteria associated with BV. However, a compromise in
the efﬁcacy of local defense mechanisms, such as disruption of
the intact epithelial barrier and activity of the local genital tract
immune system [10], may be necessary for initiation of a
clinically apparent infection. In the vagina, the innate immune
system plays an important role in prevention and control of
microbial proliferation. Vaginal epithelial and immune cells
possess Toll-like receptors (TLRs) that recognize invariant
components of many microbial invaders, and their activation
triggers an immune response [10,11]. Neutrophils are the ﬁrst
and most abundant cells recruited from the bloodstream to the
vaginal cavity in response to an altered milieu, and are
responsible for the phagocytosis of microorganisms [11]. In
the circulation, neutrophils have a short life span (less than 24 h),
but in the presence of infection survival is prolonged by exposure
to inﬂammatory mediators. There is a delay in neutrophil
apoptosis, enabling their prolonged function. Regulatory mecha-
nisms are required to limit the extent of neutrophil activity and
restore tissue homeostasis [12–15]. This is accomplished by
induction of neutrophil apoptosis. Apoptotic cells undergo
several characteristic alterations, including cell membrane
alterations which allow their engulfment by macrophages [13–
15]. CD16 is a cell surface molecule encoded by the Ig superfamily
genes (FcyRIII), and is expressed on NK cells, neutrophils and
macrophages. A reduction in CD16 expression is a surface
Fig. 1. Box plot of CD24 + (granulocytes) cell percentages present in the vaginal
lavages from women with normal ﬂora (NF) and vaginitis, including vulvovaginal
candidiasis (VC), bacterial vaginosis (BV) and BV plus VC (BV + VC). Statistics
performed with the Kruskal–Wallis test.
J. Beghini et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 167 (2013) 96–99 97biomarker for tracking neutrophil apoptosis and a decrease in
neutrophil function [15–17].
In the course of studies on immune cells present in the vaginal
lumen of women with and without vaginitis, we observed a
variation in CD16 expression on vaginal neutrophils. The aim of
this study was to compare, by ﬂow cytometry, the surface
expression of CD16 on neutrophils obtained from the vagina of
women with normal ﬂora (NF) and women with BV, VC and BV plus
VC.
2. Materials and methods
2.1. Subjects and vaginal lavage sampling
A cross-sectional study was conducted in the outpatient clinic
for genital tract infections of the ‘‘Hospital da Mulher Prof. Dr. Jose´
Aristodemo Pinotti’’ the women’s hospital of the Campinas
University (Unicamp), Campinas, Brazil. The study was performed
from June 2009 to October 2010, and 152 women were included
considering the following criteria: women with NF, women with
BV, women with VC and women with BV plus VC. All women were
of childbearing age and had initiated sexual activity. Women
having their menstrual period, pregnant, using antibiotics and/or
antifungals within seven days, and with less than 12 h since the
time of last sexual intercourse were not included. Cases with
uninterpretable test results and/or inappropriate material collect-
ed for analysis were excluded from the study. The study was
approved by the Ethics and Research Committee of the Campinas
University (Ethic permit no. 643/2008), and all subjects signed a
written informed consent form.
After an interview, women underwent a speculum-based
gynecological examination. BV was screened by the Amsel criteria
[18] and diagnosed by the Nugent score  7 [19]. VC was diagnosed
by the presence of yeast or hyphae in the vaginal discharge by
microscopy using wet mount and/or Gram-stain of vaginal ﬂuid,
and/or by culture positive for Candida sp. in Sabouraud medium. A
diagnosis of combined BV and CV was made when both criteria
were present in the same woman. Normal vaginal ﬂora were
deﬁned by the presence of type 1 ﬂora (80% or more of lactobacillus
morphotype) [20] and the absence of pathogens in the vaginal
discharge evaluated by microscopy and Gram stain, in addition to a
negative fungal culture. Vaginal lavage sampling was performed by
washing the vaginal cavity with 5 ml of PBS (phosphate buffer
solution: 0.15 M, pH 7.2: NaCl 0.137 M; KCl 0.0027 M; Na2HPO4
0.008 M; KH2PO4 0.0015 M) and retrieving the solution with a
syringe. Vaginal lavage samples were further processed for
evaluation of immune cells by ﬂow cytometry.
2.2. Sample preparation and ﬂow cytometry-based cell phenotyping
Immediately after collection of the vaginal lavage the samples
were transported to the laboratory, centrifuged (600  g/10 min),
the supernatants discarded and the pellets were suspended in 4 ml
ice cold PBS containing 2% fetal bovine serum (PBS 2% FBS).
Samples were homogenized by vortex and a quick centrifugation
was performed (600  g/30 s). One ml was taken from the upper
part of the supernatant and transferred to a conical micro-tube
(1.5 ml capacity). Samples were further washed three times
(1000  g/5 min) with 1 ml of PBS 2% FBS before phenotyping.
Cell staining was performed by mixing 100 ml of cell suspen-
sions with appropriate concentrations of ﬂuorochrome-conjugated
monoclonal-antibodies (MAb), and incubated for 30 min at 8–
12 8C in the dark. Fluorochrome-conjugated MAbs anti-CD15
(clone HI98), anti-CD16 (clone 3G8) and anti-CD24 (clone ML5)
(Becton Dickinson Biosciences, Mountain View, CA, USA) were
used alone or in combination. After the incubation period the cellswere washed twice (1000  g/5 min) and ﬁnal cell pellets were
suspended in 300 ml of PBS 2% FBS. Data acquisition was carried
out in a FACSCan (Becton Dickinson, San Jose, USA) cytometer. At
least 10,000 cells were acquired for each sample. All samples were
analyzed by gating the granulocyte population after setting
appropriately the forward (FSC) and side (SSC) light scatter
parameters, according to size and granularity of the cells.
Neutrophils were identiﬁed by the expression of CD24, CD15
and CD16 surface markers. CD16 down-regulation was assessed by
mean ﬂuorescence intensity (MFI). Cytometry analyses were
carried out by employing Cell QuestTM (Becton Dickinson, San
Jose, USA) and FlowJoTM (Treestar, Ashland, OR, USA) software.
2.3. Statistics
Data were expressed as the mean, median and standard
deviation. SAS version 9.2 was the software used for analysis.
Variables were compared between groups, using the Kruskal–
Wallis test followed by the Mann–Whitney test. The level of
signiﬁcance was set at <0.05.
3. Results
The expression of CD16 was assessed on vaginal neutrophils
from women with a vaginal disorder or with normal vaginal ﬂora.
Thirty-four women were diagnosed with BV, 43 with VC, 14 with
BV plus VC, and 51 with NF. Ten women were excluded from the
study based on exclusion criteria.
Flow cytometry allowed the quantiﬁcation of granulocytes
present in the vaginal lavages from women in our study.
Granulocytes were detected not only by their usual size and
granularity (FSC and SSC parameters), but also by the expression
of the CD24 surface molecule. The average percentage of
granulocytes was signiﬁcantly higher (p = 0.031) in women with
VC (CD24+ cells = 51.1  29.4%, median = 61.6) compared to women
with NF (CD24+ cells = 38.1  29.6%, median = 38.4) and women
with BV (CD24+ cells = 30.4  21.9%, median = 27.4) (Fig. 1). The
percentages of granulocytes in the vaginal lavages from women with
BV plus VC tended toward the levels observed for women with NF
and women with BV. Since CD24+ population was also positive for
the expression of CD15 and CD16 surface markers, it indicated that
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vaginal lavages [21].
CD16 expression on vaginal neutrophils varied among the
various diagnoses. Fig. 2 depicts a typical CD16 expression variation
by presenting ﬂow cytometry proﬁles of two different vaginal lavage
samples, one taken from a BV patient (#112) with high expression of
CD16 and another taken from a VC patient (#130) with low CD16
expression. CD16 expression was evaluated by mean ﬂuorescence
intensity (MFI) and the results are presented in Fig. 3. The MFI of the
CD16 molecule was higher in neutrophils in vaginal lavages from
women with vaginal disorders compared to women with NF. MFI
was signiﬁcantly higher (p < 0.05) in neutrophils in vaginal lavages
from women with BV (269.95  287.58, median = 164.39) and
women with VC (156.18  231.72, median = 61.35) compared to
women with NF (80.69  109.54, median = 32.26). Considering only
women with vaginal disorders, CD16 expression was signiﬁcantly
higher (p = 0.0273) in BV than in VC. In addition, the MFI in women with
BV plus VC (250.98  252.01, median = 134.18) was signiﬁcantlyFig. 2. Flow cytometry proﬁles of two vaginal lavages taken from vaginal candidiasis
(#112) and bacterial vaginosis (#130) patients. Samples were analyzed by setting
appropriate SSC/FSC gates on the granulocyte (CD24+) population. CD16 expression
on the neutrophils (CD24+ CD15+ CD16+) varies among the vaginal lavage samples.
Fig. 3. Box plot of mean ﬂuorescence intensity (MFI) of CD16 on neutrophils present
in vaginal lavages from women with normal ﬂora (NF) and vaginitis, including
vulvovaginal candidiasis (VC), bacterial vaginosis (BV) and BV plusVC (BV + VC).
Statistics were performed with the Kruskal–Wallis test.higher (p = 0.0027) compared to women with NF (Fig. 3). Presence of
erythema in the vaginal mucosa was signiﬁcantly higher (p < 0.0001)
in women with candidiasis (VC = 32.6% and BV plus VC = 57.1%), in
comparison to women with BV (2.9%) or with NF (0.0%).
4. Comments
In this study, we demonstrated that CD16 expression on
neutrophils present in the vagina appears to be affected by Candida
infection and by an alteration in the vaginal bacterial ﬂora (BV).
CD16 expression on neutrophils from women with these disorders
was not only higher compared to healthy controls but also varied
according to clinical diagnosis. Our observations can be explained
by a reduction in neutrophil apoptosis in women with these two
vaginal disorders.
Neutrophil apoptosis may be delayed, induced or enhanced by
microorganisms, depending on the immune evasion strategies
developed and the health of the host encountered by these
microorganisms [14]. During the initial phase of a microbial
infection, the release of proinﬂammatory cytokines (TNF-a, IL-1b,
IL-6, and GM-CSF) enhances activation and survival of neutrophils
and facilitates their accumulation to combat infection [22]. After
phagocytosis of bacteria and/or interaction with bacterial pro-
ducts, neutrophils initiate the apoptotic process allowing their
phagocytosis by macrophages and resolution of inﬂammation
[13,22].
Most of the studies reporting the effect of infection on
neutrophil lifespan were performed with neutrophils isolated
from peripheral blood followed by in vitro exposure of these
neutrophils to different microorganisms or microbial components
[23–25]. In contrast, in our study CD16 expression was assessed in
neutrophils present in fresh vaginal lavages obtained from women
with vaginal disorders and women with normal vaginal ﬂora.
Therefore, the alterations observed in neutrophil CD16 expression
resulted from factors present in the vaginal environment. The
lowest mean CD16 expression found in this study was in
neutrophils present in vaginal lavages from women with normal
vaginal ﬂora. This observation is compatible with low neutrophil
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previous report that Lactobacillus sp. has an apoptogenic effect on
neutrophils [26]. The induction of neutrophil apoptosis by
lactobacillus morphotypes might be a component of an immune
protective mechanism since these bacteria are the most common
microorganism present in vaginal ﬂora. In contrast, neutrophils
associated with the vaginal disorders BV and VC had a
signiﬁcantly elevated expression of CD16. This observation is
compatible with an increased functional lifespan of neutrophils in
women with these disorders. The highest average expression of
CD16 was found on neutrophils present in vaginal lavages from
women with BV. Our results also raise a question regarding short
chain fatty acids (SCFA), recently reported as an apoptogenic
substance present in high concentrations in vaginal lavages from
women with bacterial vaginosis [27]. Based on our results the
apoptogenic effect of SCFA seems to be overcome by anti-
apoptotic signals present in the vaginal environment of the
women with BV.
Neutrophils release a cytotoxic and proteolytic cocktail that
allows effective killing of invading microorganisms, but tissues at
the site of this release can be damaged by prolonged exposure to
the neutrophil products [12,14,22]. Therefore, the elevated CD16
expression and neutrophil lifespan associated with BV and VC
could damage or inﬂame the vaginal mucosa. We observed a more
intense vaginal inﬂammation in women with VC in comparison to
women with BV or with NF. A possible explanation for this
observation may be related to the elevated proportion of active
neutrophils found in the vaginal lavages from women with VC. In
women with BV, the percentages of neutrophils found in vaginal
lavages were similar to that found in women with NF, although
neutrophil survival, as measured by CD16 expression, was
increased.
The present study was limited by the number of subjects
included and the lack of other markers for apoptosis, such as
annexin-V. The reason for these limitations was the fact that the
present study emerged from another ongoing study, previously
designed for the characterization of immune cells present in the
vaginal lumen of women with and without vaginitis by ﬂow
cytometry. Nevertheless, the results allowed us to conclude
that the highest amount of vaginal neutrophils was observed
in women with VC. CD16 expression on neutrophils present in
the vagina of women with BV and VC was higher than observed
in women with NF. This observation is compatible with a
prolonged neutrophil functional lifespan in women with these
vaginitides.
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